ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

24 links0 made here, not in the record36 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05768139First-in-Human Study ofTersolisib (STX-478) asMonotherapy and inCombination With OtherAntineoplastic Agents inParticipants With AdvancedSolid TumorsEli Lilly and CompanyPhase 1/Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSBreast NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionNeoplasms by SiteThe registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedNeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseBreast DiseasesThe registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedEndometrial NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termOvarian NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termUterine Cervical NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termHead and Neck NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseSquamous Cell Carcinoma of …The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termHereditary Sensory and Auto…The registry's MeSH filing›Nov 14 · Rule based · MisfiledMisfiledDRUGSSTX-478Intervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedFulvestrantIntervention entry›Nov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerRibociclibIntervention entry›Nov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerPalbociclibIntervention entry›Nov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerLetrozoleIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundAnastrozoleIntervention entry›Nov 3 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · BackgroundBackground · optionExemestaneIntervention entry›Nov 3 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · BackgroundBackground · optionTamoxifenIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundAbemaciclibIntervention entry›Nov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerImlunestrantIntervention entry›Nov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerMetforminIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundInavolisibIntervention entry›Nov 3 · Claude Opus 5.5 · Not givenNot givenCapivasertibIntervention entry›Nov 3 · Claude Opus 5.5 · Not givenNot givenAlpelisibIntervention entry›Nov 3 · Claude Opus 5.5 · Not givenNot given

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

STX-478

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “STX-478”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3STX-478Claude Opus 5.5TestedCurrent
Nov 3FulvestrantClaude Opus 5.5Background · partnerCurrent
Nov 3RibociclibClaude Opus 5.5Background · partnerCurrent
Nov 3PalbociclibClaude Opus 5.5Background · partnerCurrent
Nov 3LetrozoleClaude Opus 5.5BackgroundCurrent
Nov 3AnastrozoleClaude Opus 5.5Background · optionCurrent
Nov 3ExemestaneClaude Opus 5.5Background · optionCurrent
Nov 3TamoxifenClaude Opus 5.5BackgroundCurrent
Nov 3AbemaciclibClaude Opus 5.5Background · partnerCurrent
Nov 3ImlunestrantClaude Opus 5.5Background · partnerCurrent
Nov 3MetforminClaude Opus 5.5BackgroundCurrent
Nov 3InavolisibClaude Opus 5.5Not givenCurrent
Nov 3CapivasertibClaude Opus 5.5Not givenCurrent
Nov 3AlpelisibClaude Opus 5.5Not givenCurrent
Nov 14Breast NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Neoplasms by SiteRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 14NeoplasmsRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Breast DiseasesRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 14Endometrial NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Ovarian NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Uterine Cervical NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Head and Neck NeoplasmsRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Squamous Cell Carcinoma of Head and NeckRule based · condition-kind ruleFinest filed termCurrent
Nov 14Hereditary Sensory and Autonomic NeuropathiesRule based · condition-kind ruleMisfiledCurrent
Nov 18STX-478Rule based · role ruleTestedAgrees
Nov 18FulvestrantRule based · role ruleBackgroundAgrees
Nov 18RibociclibRule based · role ruleBackgroundAgrees
Nov 18PalbociclibRule based · role ruleBackgroundAgrees
Nov 18LetrozoleRule based · role ruleBackgroundAgrees
Nov 18AnastrozoleRule based · role ruleBackgroundAgrees
Nov 18ExemestaneRule based · role ruleBackgroundAgrees
Nov 18TamoxifenRule based · role ruleBackgroundAgrees
Nov 18AbemaciclibRule based · role ruleBackgroundAgrees
Nov 18ImlunestrantRule based · role ruleBackgroundAgrees
Nov 18MetforminRule based · role ruleBackgroundAgrees
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.